Sorrento Therapeutics Inc
(SRNE)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2012 | 12-2011 | 12-2010 | 12-2009 | 12-2008 | |
| Sales | 584 | 529 | 683 | 0 | 0 |
| Gross Profit | 584 | 529 | 683 | N/A | N/A |
| Operating Expenses | 5,436 | 3,772 | 2,495 | 954 | 26 |
| Operating Income | -4,852 | -3,242 | -1,812 | -954 | -26 |
| Other Income | 7 | 6 | 4 | 12 | 0 |
| Pre-tax Income | -4,845 | -3,237 | -1,808 | -942 | -26 |
| Net Income Continuous | -4,845 | -3,237 | -1,808 | -942 | -26 |
| Net Income | $-4,845 | $-3,237 | $-1,808 | $-942 | $-26 |
| EPS Basic Total Ops | -0.42 | -0.01 | -0.01 | -0.01 | 0.00 |
| EPS Basic Continuous Ops | -0.42 | -0.01 | -0.01 | -0.01 | 0.00 |
| EPS Diluted Total Ops | -0.42 | -0.01 | -0.01 | -0.01 | 0.00 |
| EPS Diluted Continuous Ops | -0.42 | -0.01 | -0.01 | -0.01 | 0.00 |
| EBITDA(a) | $-4,559 | $-3,083 | $-1,789 | $-951 | $-26 |